Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1EXENATIDE[1] Exenatide (Exenatide synthetic)[1] Exenatide (Exenatide) 💬 [1] GLP1R 💬 [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[6] 6, 17, 72, 78, 193, 233 💬
2Exenatide 10 micrograms[1] Exenatide (Exenatide synthetic)[1] Exenatide (Exenatide) 💬 [1] GLP1R 💬 [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6 💬
3Exenatide 5 micrograms[1] Exenatide (Exenatide synthetic)[1] Exenatide (Exenatide) 💬 [1] GLP1R 💬 [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6 💬
4Exenatide extended release 2mg (Bydureon)[1] Exenatide (Exenatide synthetic)[1] Exenatide (Exenatide) 💬 [1] GLP1R 💬 [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6 💬
5Exenatide Pen Injector [Bydureon][1] Exenatide (Exenatide synthetic)[1] Exenatide (Exenatide) 💬 [1] GLP1R 💬 [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 17 💬
6Experimental: GLP1-RA (exenatide) administration[1] Exenatide (Exenatide synthetic)[1] Exenatide (Exenatide) 💬 [1] GLP1R 💬 [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 72, 78 💬